171 related articles for article (PubMed ID: 8014930)
1. The relationship between clinical activity and depression in rheumatoid arthritis.
Wolfe F; Hawley DJ
J Rheumatol; 1993 Dec; 20(12):2032-7. PubMed ID: 8014930
[TBL] [Abstract][Full Text] [Related]
2. Functional Health Assessment Questionnaire (HAQ) and Psychological HAQ Are Associated with and Predicted by Different Factors in Rheumatoid Arthritis.
Verstappen SM; Jacobs JW; Huisman AM; van Rijthoven AW; Sokka T; Bijlsma JW
J Rheumatol; 2007 Sep; 34(9):1837-40. PubMed ID: 17787050
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
Wolfe F; Pincus T; O'Dell J
J Rheumatol; 2001 Jul; 28(7):1712-7. PubMed ID: 11469486
[TBL] [Abstract][Full Text] [Related]
4. The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients.
Wolfe F; Hawley DJ
J Rheumatol; 1998 Nov; 25(11):2108-17. PubMed ID: 9818651
[TBL] [Abstract][Full Text] [Related]
5. The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials.
Pope JE; Khanna D; Norrie D; Ouimet JM
J Rheumatol; 2009 Feb; 36(2):254-9. PubMed ID: 19132791
[TBL] [Abstract][Full Text] [Related]
6. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
[TBL] [Abstract][Full Text] [Related]
7. Rheumatology visit frequency and changes in functional disability and pain in patients with rheumatoid arthritis.
Ward MM
J Rheumatol; 1997 Jan; 24(1):35-42. PubMed ID: 9002008
[TBL] [Abstract][Full Text] [Related]
8. Are patient self-report measures of arthritis activity confounded by mood? A longitudinal study of patients with rheumatoid arthritis.
Ward MM
J Rheumatol; 1994 Jun; 21(6):1046-50. PubMed ID: 7932413
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and meaning of fatigue in rheumatic disease.
Wolfe F; Hawley DJ; Wilson K
J Rheumatol; 1996 Aug; 23(8):1407-17. PubMed ID: 8856621
[TBL] [Abstract][Full Text] [Related]
10. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?
Ward MM
J Rheumatol; 1994 Jan; 21(1):17-27. PubMed ID: 7864914
[TBL] [Abstract][Full Text] [Related]
11. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.
Blackmore MG; Gladman DD; Husted J; Long JA; Farewell VT
J Rheumatol; 1995 May; 22(5):886-93. PubMed ID: 8587077
[TBL] [Abstract][Full Text] [Related]
12. Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.
Kwok T; Pope JE
J Rheumatol; 2010 May; 37(5):1024-8. PubMed ID: 20231193
[TBL] [Abstract][Full Text] [Related]
13. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
[TBL] [Abstract][Full Text] [Related]
14. A reappraisal of HAQ disability in rheumatoid arthritis.
Wolfe F
Arthritis Rheum; 2000 Dec; 43(12):2751-61. PubMed ID: 11145033
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis.
Wolfe F; Michaud K; Pincus T
J Rheumatol; 2005 Jul; 32(7):1261-6. PubMed ID: 15996062
[TBL] [Abstract][Full Text] [Related]
16. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
Yazici Y; Bergman M; Pincus T
J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
[TBL] [Abstract][Full Text] [Related]
17. Measuring the epidemiology of distress: the rheumatology distress index.
Wolfe F; Skevington SM
J Rheumatol; 2000 Aug; 27(8):2000-9. PubMed ID: 10955344
[TBL] [Abstract][Full Text] [Related]
18. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis?
Escalante A; del Rincón I
Arthritis Rheum; 1999 Aug; 42(8):1712-21. PubMed ID: 10446872
[TBL] [Abstract][Full Text] [Related]
19. Measurement of gold treatment effect in clinical practice: evidence for effectiveness of intramuscular gold therapy.
Wolfe F; Hawley DJ; Cathey MA
J Rheumatol; 1993 May; 20(5):797-802. PubMed ID: 8336305
[TBL] [Abstract][Full Text] [Related]
20. The minimally important difference in clinical practice for patient-centered outcomes including health assessment questionnaire, fatigue, pain, sleep, global visual analog scale, and SF-36 in scleroderma.
Sekhon S; Pope J; ; Baron M
J Rheumatol; 2010 Mar; 37(3):591-8. PubMed ID: 20080913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
